CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

NCT00075647 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

NIH

Sponsor class

Conditions

Adenocarcinoma of the Pancreas
Recurrent Pancreatic Cancer
Stage II Pancreatic Cancer
Stage III Pancreatic Cancer
Stage IV Pancreatic Cancer

Interventions

DRUG: temsirolimus
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)